Kestra Advisory Services’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-5,133
Closed -$282K 2216
2021
Q3
$282K Buy
+5,133
New +$269K ﹤0.01% 1718
2021
Q1
Sell
-6,155
Closed -$376K 2089
2020
Q4
$376K Buy
+6,155
New +$382K ﹤0.01% 1351

Other funds holding SILK

Kestra Advisory Services's SILK Position: Q4 2021 in Review

Kestra Advisory Services sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2021, closing a stake of 5,133 shares — an estimated $282K sold.

Kestra Advisory Services first reported a position in SILK in Q4 2020 and held it in 2 quarters. The position peaked at $376K in Q4 2020. 152 funds tracked by Wall St. Rank hold SILK as of Q4 2021.

  • Kestra Advisory Services reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Kestra Advisory Services sold 5,133 Silk Road Medical, Inc. Common Stock shares in Q4 2021, an estimated $282K.
  • Kestra Advisory Services first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Kestra Advisory Services's Silk Road Medical, Inc. Common Stock position peaked at $376K in Q4 2020.
  • 152 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2021.

Based on Kestra Advisory Services's 13F filing for Q4 2021, filed 20 Jan 2022.